The active ingredient in Actos (pioglitazone) is also sold in combination with metformin (Actoplus Met®, Actoplus Met XR®) and glimepiride (Duetact®). From January 2010 through October 2010, approximately 2.3 million patients filled prescriptions for a pioglitazone-containing product from outpatient retail pharmacies.
If you or someone you love has taken a diabetes medication containing pioglitazone and was diagnosed with bladder cancer, you may be entitled to compensation. Contact us immediately for a free and confidential case evaluation, and get the help you deserve.
Never stop taking any medication without first consulting your doctor. Actos®, Actoplus Met®, Actoplus Met XR®, and Duetact® are registered trademarks of Takeda Pharmaceutical Company Limited and are used here only for the purpose of identifying the products in question. This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration, Takeda Pharmaceutical Company Limited, Eli Lilly & Company, or Bloomberg.